Shares of Ginkgo Bioworks Holdings Inc. (DNA) plummeted 5.05% in intraday trading on Thursday, underperforming the broader market. The stock's decline comes amidst allegations of a baby swap incident at a partner hospital, Rumah Sakit Islam Cempaka Putih, located in Jakarta, Indonesia.
According to reports, a father named MR has accused the hospital of switching his newborn baby with another infant. The situation unfolded when MR noticed discrepancies between the appearance of his baby during the adzani ritual and the infant's body that was later presented for burial. MR's wife, FS, had given birth at the hospital on September 16th, 2024, but tragically, the baby passed away the following day under unexplained circumstances.
In response to the allegations, Rumah Sakit Islam Cempaka Putih has agreed to facilitate DNA testing to determine the truth. The hospital has committed to fully covering the costs of the DNA tests, allowing MR and his family to choose a testing facility they trust. However, reports suggest that the hospital has requested MR's employer to initially pay for the tests, with the promise of reimbursement from the hospital.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。